Vildafp-M500

Vildagliptin 50 mg & Metformin Hydrochloride 500 mg Tablet

Vildagliptin binds covalently to DPP-4’s catalytic site, causing the enzyme to be inhibited for a long time. This raises intact GLP-1 levels in both the fasted and post-meal states. Vildagliptin stimulates insulin secretion while inhibiting glucagon secretion in a glucose-dependent manner.

Metformin is a metabolic inhibitor that affects energy metabolism in both the whole body and the cells. It is mostly utilised in individuals with type 2 diabetes, and its principal mechanism of action in this condition is hepatic gluconeogenesis inhibition.